Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.

Tanasescu R, Midgley A, Robins RA, Constantinescu CS.

Acta Neurol Scand. 2017 Sep;136(3):233-238. doi: 10.1111/ane.12715. Epub 2016 Dec 5.

PMID:
27918083
2.

Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.

Jean-Gilles L, Braitch M, Latif ML, Aram J, Fahey AJ, Edwards LJ, Robins RA, Tanasescu R, Tighe PJ, Gran B, Showe LC, Alexander SP, Chapman V, Kendall DA, Constantinescu CS.

Acta Physiol (Oxf). 2015 May;214(1):63-74. doi: 10.1111/apha.12474. Epub 2015 Mar 10.

3.

Regulation in chronic obstructive pulmonary disease: the role of regulatory T-cells and Th17 cells.

Lane N, Robins RA, Corne J, Fairclough L.

Clin Sci (Lond). 2010 Apr 20;119(2):75-86. doi: 10.1042/CS20100033. Review.

PMID:
20402669
4.

Th17/Th1 phenotype in demyelinating disease.

Edwards LJ, Robins RA, Constantinescu CS.

Cytokine. 2010 Apr;50(1):19-23. doi: 10.1016/j.cyto.2009.12.003. Epub 2010 Jan 4.

PMID:
20045653
5.

Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosis.

Braitch M, Kawabe K, Nyirenda M, Gilles LJ, Robins RA, Gran B, Murphy S, Showe L, Constantinescu CS.

Neuroimmunomodulation. 2010;17(2):120-5. doi: 10.1159/000258695. Epub 2009 Nov 17.

6.

Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs.

Aloysius MM, Mc Kechnie AJ, Robins RA, Verma C, Eremin JM, Farzaneh F, Habib NA, Bhalla J, Hardwick NR, Satthaporn S, Sreenivasan T, El-Sheemy M, Eremin O.

J Transl Med. 2009 Mar 19;7:18. doi: 10.1186/1479-5876-7-18.

7.

Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis.

Braitch M, Harikrishnan S, Robins RA, Nichols C, Fahey AJ, Showe L, Constantinescu CS.

Acta Neurol Scand. 2009 Apr;119(4):239-45. doi: 10.1111/j.1600-0404.2008.01090.x.

8.

Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha.

Satthaporn S, Aloysius MM, Robins RA, Verma C, Chuthapisith S, McKechnie AJ, El-Sheemy M, Vassanasiri W, Valerio D, Clark D, Jibril JA, Eremin O.

BMC Immunol. 2008 Jun 27;9:32. doi: 10.1186/1471-2172-9-32.

9.

Kinetics of immune cell migration at the human ocular surface.

Chan JH, Amankwah R, Robins RA, Gray T, Dua HS.

Br J Ophthalmol. 2008 Jul;92(7):970-5. doi: 10.1136/bjo.2007.131003.

PMID:
18577649
10.

Reciprocal effects of IFN-beta and IL-12 on STAT4 activation and cytokine induction in T cells.

Fahey AJ, Robins RA, Constantinescu CS.

J Leukoc Biol. 2007 Jun;81(6):1562-7. Epub 2007 Mar 9.

PMID:
17351016
11.

A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.

Ullenhag GJ, Spendlove I, Watson NF, Indar AA, Dube M, Robins RA, Maxwell-Armstrong C, Scholefield JH, Durrant LG.

Clin Cancer Res. 2006 Dec 15;12(24):7389-96. Epub 2006 Nov 22.

12.

Vaccination therapy in malignant disease.

Aloysius MM, Robins RA, Eremin JM, Eremin O.

Surgeon. 2006 Oct;4(5):309-20. Review.

PMID:
17009550
13.

Effects of glucocorticoids on STAT4 activation in human T cells are stimulus-dependent.

Fahey AJ, Robins RA, Kindle KB, Heery DM, Constantinescu CS.

J Leukoc Biol. 2006 Jul;80(1):133-44. Epub 2006 May 2.

PMID:
16670125
14.

Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.

Nowlan ML, Drewe E, Bulsara H, Esposito N, Robins RA, Tighe PJ, Powell RJ, Todd I.

Rheumatology (Oxford). 2006 Jan;45(1):31-7. Epub 2005 Nov 15.

PMID:
16287931
15.

Vaccination and malignant disease: promising therapeutic approach.

McKechnie A, Robins RA, Eremin O.

Surgeon. 2005 Jun;3(3):224-33. Review.

PMID:
16076009
16.

HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix.

McClure CP, Tighe PJ, Robins RA, Bansal D, Bowman CA, Kingston M, Ball JK.

AIDS. 2005 Aug 12;19(12):1257-65.

PMID:
16052080
17.
18.

Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.

Damanhouri LH, Dromey JA, Christie MR, Nasrat HA, Ardawi MS, Robins RA, Todd I.

Diabet Med. 2005 Apr;22(4):448-52.

PMID:
15787671
19.

Monocytes are highly sensitive to clostridium difficile toxin A-induced apoptotic and nonapoptotic cell death.

Solomon K, Webb J, Ali N, Robins RA, Mahida YR.

Infect Immun. 2005 Mar;73(3):1625-34.

20.

Immunological aspects of head and neck cancer: biology, pathophysiology and therapeutic mechanisms.

McKechnie A, Robins RA, Eremin O.

Surgeon. 2004 Aug;2(4):187-207. Review.

PMID:
15570827
21.

Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.

Murray JC, Heng YM, Symonds P, Rice K, Ward W, Huggins M, Todd I, Robins RA.

J Leukoc Biol. 2004 May;75(5):772-6. Epub 2004 Feb 24.

PMID:
14982944
22.

Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.

Murray JC, Symonds P, Ward W, Huggins M, Tiga A, Rice K, Heng YM, Todd I, Robins RA.

J Immunol. 2004 Jan 1;172(1):274-81.

23.
24.

Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients.

Durrant LG, Chapman MA, Buckley DJ, Spendlove I, Robins RA, Armitage NC.

Cancer Immunol Immunother. 2003 Oct;52(10):638-42. Epub 2003 Jun 14.

PMID:
12811528
25.

International conference: progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK.

Rees RC, Robins RA, Pawelec G, Muller L, Li G, Spendlove I.

Cancer Immunol Immunother. 2003 Jun;52(6):403-7. Epub 2003 Apr 9. No abstract available.

PMID:
12684847
26.
27.

Loss of cytomegalovirus-specific immunological memory in a patient with thymoma.

Huissoon AP, Davies G, Cox RA, Sloper CM, Thomson BJ, Robins RA.

Clin Exp Immunol. 2002 Aug;129(2):297-301.

28.

S antigen specific effector T cell activation detected by cytokine flow cytometry.

Morgan JP, Robins RA, Dua HS, Tighe PJ.

Br J Ophthalmol. 2002 May;86(5):517-20.

29.

Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection.

Grabowska AM, Lechner F, Klenerman P, Tighe PJ, Ryder S, Ball JK, Thomson BJ, Irving WL, Robins RA.

Eur J Immunol. 2001 Aug;31(8):2388-94.

30.

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer.

Maxwell-Armstrong CA, Durrant LG, Buckley TJ, Scholefield JH, Robins RA, Fielding K, Monson JR, Guillou P, Calvert H, Carmichael J, Hardcastle JD.

Br J Cancer. 2001 Jun 1;84(11):1443-6.

31.

Vaccine-induced apoptosis: a novel clinical trial end point?

Amin S, Robins RA, Maxwell-Armstrong CA, Scholefield JH, Durrant LG.

Cancer Res. 2000 Jun 15;60(12):3132-6.

32.

Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.

Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.

Cancer Res. 2000 Mar 15;60(6):1663-70.

33.

A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55.

Durrant LG, Maxwell-Armstrong C, Buckley D, Amin S, Robins RA, Carmichael J, Scholefield JH.

Clin Cancer Res. 2000 Feb;6(2):422-30.

34.

Counting antigens using antibodies.

Robins RA.

Immunol Today. 2000 Mar;21(3):154-5. No abstract available.

PMID:
10689304
35.

Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.

Jenkins D, Seth R, Kummer JA, Scott BB, Hawkey CJ, Robins RA.

J Pathol. 2000 Feb;190(2):184-9.

PMID:
10657017
36.

Co-cultivation of CD4+ and CD8+ human T-cells leads to the appearance of CD4 cells expressing CD8 through de novo synthesis of the CD8 alpha-subunit.

O'Donovan MR, Jones DR, Robins RA, Li KF, Shim HK, Zheng Z, Arlett CF, Capulas E, Cole J.

Hum Immunol. 1999 Nov;60(11):1018-27.

PMID:
10599998
38.

Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7.

Maxwell-Armstrong CA, Durrant LG, Robins RA, Galvin AM, Scholefield JH, Hardcastle JD.

Gut. 1999 Oct;45(4):593-8.

39.

Multiple immunofluorescence analysis of cells using flow cytometry.

Robins RA.

Methods Mol Biol. 1998;80:337-46. No abstract available.

PMID:
9664391
40.

Flow cytometric analysis of cell surface antigen density.

Robins RA.

Methods Mol Biol. 1998;80:319-36. No abstract available.

PMID:
9664390
41.

Tumour immunology: false hopes--new horizons?

Alexandroff AB, Robins RA, Murray A, James K.

Immunol Today. 1998 Jun;19(6):247-50. No abstract available.

PMID:
9639986
42.

Peripheral blood lymphocyte binding to a soluble FITC-fibronectin conjugate.

Pallis M, Robins RA, Powell RJ.

Cytometry. 1997 Jun 1;28(2):157-64.

43.

Low doses of 105AD7 cancer vaccine preferentially stimulate anti-tumor T-cell immunity.

Durrant LG, Buckley DJ, Spendlove I, Robins RA.

Hybridoma. 1997 Feb;16(1):23-6.

PMID:
9085124
44.

Correlation between CD29 density on CD8+ lymphocytes and serum IgG in systemic lupus erythematosus.

Pallis M, Lim KL, Gardner-Medwin JM, Robins RA, Powell RJ.

Lupus. 1997;6(4):379-84.

PMID:
9175023
45.

Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation.

McLaughlan JM, Seth R, Vautier G, Robins RA, Scott BB, Hawkey CJ, Jenkins D.

J Pathol. 1997 Jan;181(1):87-92.

PMID:
9072008
46.

Peripheral blood lymphocyte adhesion molecule deployment in the immune response.

Pallis M, Robins RA, Powell RJ.

Scand J Immunol. 1996 Mar;43(3):304-13.

PMID:
8602465
47.

Peripheral blood based T cell-containing and T cell-depleted culture systems for human IgE synthesis: the role of T cells.

Wheeler DJ, Robins RA, Pritchard DI, Bundick RV, Shakib F.

Clin Exp Allergy. 1996 Jan;26(1):28-35.

PMID:
8789540
48.

A flow cytometric method to measure shape change of human neutrophils.

Cole AT, Garlick NM, Galvin AM, Hawkey CJ, Robins RA.

Clin Sci (Lond). 1995 Nov;89(5):549-54.

PMID:
8549071
49.

What you need to know when you go with the flow: pitfalls in the use of flow cytometry.

Pallis M, Robins RA.

Ann Rheum Dis. 1995 Oct;54(10):785-6. No abstract available.

Supplemental Content

Loading ...
Support Center